Eli Lilly EBITDA 2010-2024 | LLY

Eli Lilly EBITDA for the quarter ending September 30, 2024 was $4.820B, a 25.62% increase year-over-year.

  • Eli Lilly 2023 EBITDA was 7.985B, a 7.68% decline from 2022.
  • Eli Lilly 2022 EBITDA was 8.65B, a 9.43% increase from 2021.
  • Eli Lilly 2021 EBITDA was 7.905B, a 7.08% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Eli Lilly EBITDA 2010-2024 | LLY

  • Eli Lilly 2023 EBITDA was 7.985B, a 7.68% decline from 2022.
  • Eli Lilly 2022 EBITDA was 8.65B, a 9.43% increase from 2021.
  • Eli Lilly 2021 EBITDA was 7.905B, a 7.08% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B